Glucagon-Like Peptide-1 Receptor: A Novel Receptor in Platelets

被引：0
作者：
Kahal, Hassan
Aburima, Ahmed
Spurgeon, Benjamin
Wraith, Katie S.
Ghavideldarestani, Maryam
Rizvi, Faran
Sturmey, Roger G.
Kilpatrick, Eric S.
Atkin, Stephen L.
Naseem, Khalid M.
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2062-P
引用
收藏
页码：A528 / A528
页数：1
相关论文
共 50 条
  • [41] Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
    During, MJ
    Cao, L
    Zuzga, DS
    Francis, JS
    Fitzsimons, HL
    Jiao, XY
    Bland, RJ
    Klugmann, M
    Banks, WA
    Drucker, DJ
    Haile, CN
    NATURE MEDICINE, 2003, 9 (09) : 1173 - 1179
  • [42] Evaluating the glucagon-like peptide-1 receptor in managing asthma
    Wu, Ashley Y.
    Cahill, Katherine N.
    Toki, Shinji
    Peebles, R. Stokes, Jr.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 22 (01) : 36 - 41
  • [43] Weighing in on glucagon-like peptide-1 receptor agonists in dermatology
    Heymann, Warren R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (01) : 29 - 30
  • [44] The complexity of signalling mediated by the glucagon-like peptide-1 receptor
    Fletcher, Madeleine M.
    Halls, Michelle L.
    Christopoulos, Arthur
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 582 - 588
  • [45] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [46] Can epicardial fat glucagon-like peptide-1 receptor open up to the cardiovascular benefits of glucagon-like peptide-1 analogues?
    Iacobellis, Gianluca
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (03): : 224 - 225
  • [47] Effects of gastric inhibitory polypeptide, glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists on Bone Cell Metabolism
    Hansen, Morten S. S.
    Tencerova, Michaela
    Frolich, Jacob
    Kassem, Moustapha
    Frost, Morten
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (01) : 25 - 37
  • [48] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
    De Block, Christophe E. M.
    Dirinck, Eveline
    Verhaegen, Ann
    Van Gaal, Luc F.
    DIABETES OBESITY & METABOLISM, 2022, 24 (05) : 788 - 805
  • [49] Hydrocarbon-Stitched Peptide Agonists of Glucagon-Like Peptide-1 Receptor
    Bird, Gregory H.
    Fu, Accalia
    Escudero, Silvia
    Godes, Marina
    Opoku-Nsiah, Kwadwo
    Wales, Thomas E.
    Cameron, Michael D.
    Engen, John R.
    Danial, Nika N.
    Walensky, Loren D.
    ACS CHEMICAL BIOLOGY, 2020, 15 (06) : 1340 - 1348
  • [50] Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects
    Murakami, Takaaki
    Fujimoto, Hiroyuki
    Fujita, Naotaka
    Hamamatsu, Keita
    Yabe, Daisuke
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1448 - 1456
12345